| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/2000 | WO2000004145A3 Myotilin, an actin-organizing protein |
| 04/20/2000 | WO2000004052A3 Soluble derivatives of anti-angiogenic peptides |
| 04/20/2000 | WO2000004040A3 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 04/20/2000 | WO2000003687A3 Potassium channel polypeptide and polynucleotide compositions |
| 04/20/2000 | WO2000001832A3 Inducible promoters |
| 04/20/2000 | WO2000001814A3 Non-human mammal wherein a gene coding for an scuz-protein can be de-activated in a time-specific or tissue-specific manner |
| 04/20/2000 | WO2000001718A3 Ns4a-ns3 catalytic domain of hepatitis c |
| 04/20/2000 | WO2000001717A3 A method of identifying hormone receptor ligands |
| 04/20/2000 | WO2000001440A3 Methods for treating neurological injuries and disorders |
| 04/20/2000 | WO2000000515A3 A CHEMOKINE RECEPTOR OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN |
| 04/20/2000 | WO2000000506A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 04/20/2000 | WO1999067407A3 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/20/2000 | WO1999066032A3 Cells, genetically modified with optical marker |
| 04/20/2000 | WO1999065712A3 Glycosulfopeptides and methods of synthesis and use thereof |
| 04/20/2000 | WO1999065450A3 Immunosuppressive agents that inhibit calcineurin function and uses thereof |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999063086B1 Insulin-like growth factor binding protein-3 variants |
| 04/20/2000 | WO1999063068A9 Phenotype modifying genetic sequences |
| 04/20/2000 | WO1999062943A3 Novel molecules of the aip-related protein family and uses thereof |
| 04/20/2000 | WO1999061653A3 Light-mediated regional analysis of biologic material |
| 04/20/2000 | WO1999061469A3 Prostate growth-associated membrane proteins |
| 04/20/2000 | WO1999060986A3 Apoptosis modulators that interact with the huntington's disease gene |
| 04/20/2000 | WO1999059630A9 Type iii bordetella secretion system |
| 04/20/2000 | WO1999058665A3 Isolation and use of fetal urogenital sinus expressed sequences |
| 04/20/2000 | WO1999058658A3 Expression vectors for stimulating an immune response and methods of using the same |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | WO1999055901A3 Screening assay for identifying human purinoreceptor ligands |
| 04/20/2000 | WO1999055861A3 Fibroblast growth factor mutein compositions and methods of use therefor |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | DE19847690A1 Diagnosing sepsis and severe infections, useful for assessing severity and progress of treatment, by measuring content of peptide prohormone or their derived fragments |
| 04/20/2000 | DE19847628A1 Outer membrane protein of Helicobacter pylori and DNA sequences, useful in vaccines and for production of diagnostic or therapeutic antibodies |
| 04/20/2000 | DE19847362A1 New polycyclic aromatic compound-protein conjugates, useful for detection and/or treatment of diseased tissue, e.g. tumors or inflammation sites |
| 04/20/2000 | DE19847064A1 Mutant AMPA-type glutamate receptor, useful for identifying receptor agonists and antagonists, lacks the desensitizing properties of the wild-type receptor |
| 04/20/2000 | DE19846011A1 Purification of granulocyte preparations useful for transfusion comprises removing nonfunctional granulocytes |
| 04/20/2000 | CA2348688A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2348003A1 Novel interferon stimulated and repressed genes |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347247A1 Genes for assessing cardiovascular status and compositions for use thereof |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346776A1 Non-desensitizing ampa-receptors |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346501A1 Method for amplifying foreign genes |
| 04/20/2000 | CA2346466A1 Method for preserving a hemoglobin blood substitute |
| 04/20/2000 | CA2346263A1 Nucleic acids that control reproductive development in plants |
| 04/20/2000 | CA2346218A1 Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell |
| 04/20/2000 | CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | CA2346008A1 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | CA2345900A1 Selectively replicating viral vectors |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2345211A1 Recombinant e1a deleted adenoviral vectors |
| 04/20/2000 | CA2345046A1 Materials and methods for the modification of plant cell wall polysaccharides |
| 04/20/2000 | CA2344998A1 Nucleic acids encoding human cide-b protein and polymorphic markers thereof |
| 04/20/2000 | CA2344978A1 Genes, proteins and biallelic markers related to central nervous system disease |
| 04/20/2000 | CA2344853A1 Assay for disease related conformation of a protein |
| 04/20/2000 | CA2344711A1 Expression and secretion of icil-1 receptor antagonist type ii |
| 04/20/2000 | CA2344465A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2326675A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994190A2 DNA conferring L-homoserine resistance to bacteria, and its use |
| 04/19/2000 | EP0994188A1 Method for obtaining active beta-NGF |
| 04/19/2000 | EP0994121A2 Branched peptides in assays for antibodies |
| 04/19/2000 | EP0994120A1 Process to remove lipopolysaccharides from aqueous solution of proteins |
| 04/19/2000 | EP0993616A1 Reagent for detecting and monitoring viral infections |
| 04/19/2000 | EP0993470A2 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 04/19/2000 | EP0993469A1 COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| 04/19/2000 | EP0993307A2 TECHNETIUM-99m LABELED CHELATOR INCORPORATED CYCLIC PEPTIDES |
| 04/19/2000 | EP0821730A4 Chimeric receptors for regulating cellular proliferation and effector function |
| 04/19/2000 | EP0789711B1 Identification of the p21-waf1 -pcna interaction site and therapeutic applications thereof |
| 04/19/2000 | EP0677109B1 Expression system for producing apolipoprotein ai-m |
| 04/19/2000 | EP0667872B1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 04/19/2000 | EP0598840B1 Human calcium channel compositions and methods |
| 04/19/2000 | EP0550561B1 Purification of cytokeratin fragments |
| 04/19/2000 | EP0222835B2 Oral vaccines |
| 04/19/2000 | CN1251136A Plant with modified growth |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251132A Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 04/19/2000 | CN1251131A Enhancement of growth in plant |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/19/2000 | CN1251041A Fine tuned progegrins |
| 04/19/2000 | CN1250781A Process for extracting substance like acidic mechanocyte growth factor from cardiac muscle of mammal |
| 04/19/2000 | CN1250780A Shark liver irritant for preventing and curing hepatism and its preparing process |
| 04/18/2000 | US6051760 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 04/18/2000 | US6051758 Recombinant sweet protein mabinlin |
| 04/18/2000 | US6051698 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 04/18/2000 | US6051697 Chemokine expressed in eosinophils |
| 04/18/2000 | US6051692 Amino acid sequence; for prevention, treatment and diagnosis of disorders associated with cellular development and differentiation and retinoid metabolism; vision defects; skin disorders; urogenital disorders; addison's disease |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051690 NSP molecules |
| 04/18/2000 | US6051689 Receptor for the glucagon-like-peptide (GLP-1) |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051559 Cloning and characterizing of genes associated with long-term memory |
| 04/18/2000 | US6051556 Hybrid pesticidal toxins |
| 04/18/2000 | US6051555 Administering a peptide |